↓ Skip to main content

Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism

Overview of attention for article published in Cochrane database of systematic reviews, January 2006
Altmetric Badge

Mentioned by

twitter
1 tweeter

Citations

dimensions_citation
53 Dimensions

Readers on

mendeley
34 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Published in
Cochrane database of systematic reviews, January 2006
DOI 10.1002/14651858.cd001367.pub2
Pubmed ID
Authors

Hutten BA, Prins MH

Abstract

Currently, the most frequently used secondary treatment for patients with venous thromboembolism is vitamin K antagonists targeted at an INR of 2.5 (range 2.0 to 3.0). However, based on the continuing risk of bleeding and uncertainty regarding the risk of recurrent venous thromboembolism, there is discussion on the proper duration of treatment with vitamin K antagonists for these patients. Recently, several studies were published in which the risk and benefits of different durations of oral anticoagulants were compared in patients with venous thromboembolism.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 34 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
France 2 6%
Netherlands 2 6%
United Kingdom 1 3%
Unknown 29 85%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 18%
Student > Ph. D. Student 5 15%
Other 5 15%
Student > Master 5 15%
Student > Bachelor 4 12%
Other 9 26%
Readers by discipline Count As %
Medicine and Dentistry 26 76%
Unspecified 3 9%
Agricultural and Biological Sciences 2 6%
Biochemistry, Genetics and Molecular Biology 1 3%
Economics, Econometrics and Finance 1 3%
Other 1 3%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 February 2012.
All research outputs
#9,676,703
of 12,100,779 outputs
Outputs from Cochrane database of systematic reviews
#6,523
of 7,978 outputs
Outputs of similar age
#79,234
of 111,446 outputs
Outputs of similar age from Cochrane database of systematic reviews
#85
of 100 outputs
Altmetric has tracked 12,100,779 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 7,978 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.6. This one is in the 3rd percentile – i.e., 3% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 111,446 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 13th percentile – i.e., 13% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 100 others from the same source and published within six weeks on either side of this one. This one is in the 2nd percentile – i.e., 2% of its contemporaries scored the same or lower than it.